Scholar Rock SRRK Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Edgewise Therapeutics, Inc.EWTX

$1.02M+1.6%

PTC TherapeuticsPTCT

$12.08M+5.4%

Dyne Therapeutics, Inc.DYN

$5.03M-1.5%

Solid Biosciences Inc.SLDB

$2.23M+15.0%

CalAmpCAMP

$384K-87.5%

BiohavenBHVN

$5.9M+25.3%

FAQ

What is Scholar Rock's operating lease liabilities (current)?

Scholar Rock (SRRK) reported operating lease liabilities (current) of $6.32M in Q2 2026.

How has Scholar Rock's operating lease liabilities (current) changed year-over-year?

Scholar Rock's operating lease liabilities (current) increased by 21.2% year-over-year, from $5.21M to $6.32M.

What is the long-term trend for Scholar Rock's operating lease liabilities (current)?

Over 5 years (2020 to 2025), Scholar Rock's operating lease liabilities (current) has grown at a 0.7% compound annual growth rate (CAGR), from $5.37M to $5.55M.

What does operating lease liabilities (current) mean?

The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.